FI920732A0 - 2-SUBSTITUERADE KINOLINER, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA I CEILING MODEL. - Google Patents

2-SUBSTITUERADE KINOLINER, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA I CEILING MODEL.

Info

Publication number
FI920732A0
FI920732A0 FI920732A FI920732A FI920732A0 FI 920732 A0 FI920732 A0 FI 920732A0 FI 920732 A FI920732 A FI 920732A FI 920732 A FI920732 A FI 920732A FI 920732 A0 FI920732 A0 FI 920732A0
Authority
FI
Finland
Prior art keywords
dessa
kinoliner
substituerade
foerfarande foer
foer framstaellning
Prior art date
Application number
FI920732A
Other languages
Finnish (fi)
Other versions
FI920732A (en
Inventor
Siegfried Raddatz
Klaus-Helmut Mohrs
Michael Matzke
Romanis Fruchtmann
Armin Hatzelmann
Christian Kohlsdorfer
Reiner Muller-Peddinghaus
Pia Theisen-Popp
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI920732A0 publication Critical patent/FI920732A0/en
Publication of FI920732A publication Critical patent/FI920732A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Earth Drilling (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)

Abstract

2-substituted quinolines of the general formula <IMAGE> The title compounds are prepared by reacting either the corresponding halomethylquinolines with substituted phenols, then optionally alkylating these and hydrolysing esters to acids, or by reacting phenyl-substituted quinolinecarboxylic acid derivatives with sulphonamides. The novel phenyl-substituted quinolines can be used as active compounds in medicaments, in particular as lipoxygenase inhibitors.
FI920732A 1991-02-22 1992-02-20 2-SUBSTITUERADE KINOLINER, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA I CEILING MODEL FI920732A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4105551A DE4105551A1 (en) 1991-02-22 1991-02-22 2-SUBSTITUTED CHINOLINES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS

Publications (2)

Publication Number Publication Date
FI920732A0 true FI920732A0 (en) 1992-02-20
FI920732A FI920732A (en) 1992-08-23

Family

ID=6425643

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920732A FI920732A (en) 1991-02-22 1992-02-20 2-SUBSTITUERADE KINOLINER, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA I CEILING MODEL

Country Status (20)

Country Link
EP (1) EP0499926B1 (en)
JP (1) JPH0592957A (en)
KR (1) KR920016424A (en)
AT (1) ATE142623T1 (en)
AU (1) AU641585B2 (en)
CZ (1) CZ282723B6 (en)
DE (2) DE4105551A1 (en)
DK (1) DK0499926T3 (en)
ES (1) ES2091958T3 (en)
FI (1) FI920732A (en)
GR (1) GR3021014T3 (en)
HU (1) HUT67037A (en)
IE (1) IE75728B1 (en)
IL (1) IL101009A (en)
MY (1) MY108459A (en)
NZ (1) NZ241654A (en)
PL (2) PL170726B1 (en)
RU (1) RU2077532C1 (en)
TW (1) TW200463B (en)
ZA (1) ZA921268B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4226649A1 (en) * 1992-08-12 1994-02-17 Bayer Ag New isobutyl-substituted methanesulfonyl-quinolylmethoxyphenyl-cycloalkylacetic acid aminols
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4112533A1 (en) * 1991-04-17 1992-10-22 Bayer Ag METHOD FOR THE PRODUCTION OF ENANTIOMER-PURE SUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL ACETIC ACIDS
US5391555A (en) * 1991-11-12 1995-02-21 Miles Inc. Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors
TW232013B (en) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
DE4219765A1 (en) * 1992-06-17 1993-12-23 Bayer Ag Substituted (benzothiazolyl and quinoxalyl-methoxy) phenylacetic acid derivatives
DE4301900A1 (en) * 1993-01-25 1994-07-28 Bayer Ag 2-oxoquinoline-1-yl-methylphenylessigsäurederivate
ES2061406B1 (en) * 1993-05-07 1995-06-01 Uriach & Cia Sa J NEW DERIVATIVES OF 2- (QUINOLINE) WITH PHARMACOLOGICAL ACTIVITY.
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
EP0634169B1 (en) * 1993-06-29 2000-01-05 Takeda Chemical Industries, Ltd. Quinoline or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis
DE4443892A1 (en) * 1994-12-09 1996-06-13 Bayer Ag 4- (Quinolin-2-yl-methoxy) phenyl acetic acid derivatives
DE4443891A1 (en) 1994-12-09 1996-06-13 Bayer Ag Heterocyclically substituted oxy-phenyl- (phenyl) glycinolamides
US6867320B2 (en) 2002-02-21 2005-03-15 Asahi Kasei Pharma Corporation Substituted phenylalkanoic acid derivatives and use thereof
BRPI0417543A (en) 2003-12-12 2007-03-27 Wyeth Corp quinolines useful in treating cardiovascular disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (en) * 1988-04-29 1989-11-09 Bayer Ag (ALPHA) -SUBSTITUTED 4- (CHINOLIN-2-YL-METHOXY) PHENYL ACETIC ACIDS AND SITES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICAMENTS
DE3900261A1 (en) * 1988-05-31 1989-12-07 Bayer Ag SUBSTITUTED 4- (CHINOLIN-2-YL-METHOXY) PHENYL-ACETIC ACID DERIVATIVES
DE3908298A1 (en) * 1989-03-14 1990-09-20 Bayer Ag SUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL-N, N'-SULFONYL HARVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICAMENTS
DE3916663A1 (en) * 1989-05-23 1990-11-29 Bayer Ag SUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL-ACYL-SULPHONAMIDES AND CYANAMIDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICAMENTS
DE3927931A1 (en) * 1989-08-24 1991-02-28 Bayer Ag DISUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL ACETIC DERIVATIVES
DE3927930A1 (en) * 1989-08-24 1991-02-28 Bayer Ag CYCLIC SUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL-VINEGAR-ACID DERIVATIVES

Also Published As

Publication number Publication date
EP0499926A1 (en) 1992-08-26
PL171026B1 (en) 1997-02-28
IE75728B1 (en) 1997-09-24
HUT67037A (en) 1995-01-30
IL101009A0 (en) 1992-11-15
ZA921268B (en) 1992-11-25
AU1054292A (en) 1992-08-27
ATE142623T1 (en) 1996-09-15
AU641585B2 (en) 1993-09-23
DK0499926T3 (en) 1997-02-10
MY108459A (en) 1996-09-30
IL101009A (en) 1996-08-04
PL170726B1 (en) 1997-01-31
DE59207074D1 (en) 1996-10-17
FI920732A (en) 1992-08-23
EP0499926B1 (en) 1996-09-11
IE920557A1 (en) 1992-08-26
PL293534A1 (en) 1992-10-05
CS51492A3 (en) 1992-12-16
CZ282723B6 (en) 1997-09-17
HU9200582D0 (en) 1992-05-28
ES2091958T3 (en) 1996-11-16
GR3021014T3 (en) 1996-12-31
JPH0592957A (en) 1993-04-16
TW200463B (en) 1993-02-21
NZ241654A (en) 1994-11-25
DE4105551A1 (en) 1992-08-27
KR920016424A (en) 1992-09-24
RU2077532C1 (en) 1997-04-20

Similar Documents

Publication Publication Date Title
FI920732A (en) 2-SUBSTITUERADE KINOLINER, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA I CEILING MODEL
JPS5547658A (en) Substituted quinolinecarboxylic acid derivative
DE69411625D1 (en) Benzofuranyl and thiophenylalkane carboxylic acid derivatives
ATE145201T1 (en) DIHYDRO-ISOQUINOLINE DERIVATIVES
DK543787A (en) NAPHTHYRIDINE, QUINOLINE AND BENZOXAZINE CARBOXYLIC ACID COMPOUNDS WITH ANTIBACTERIAL ACTIVITY
DE58904459D1 (en) IF NECESSARY, ALPHA-SUBSTITUTED 4- (CHINOLIN-2-YL-METHOXY) PHENYL ACETIC ACIDS AND ESTERS.
NO884958L (en) Quinoline carboxylic acid derivatives.
EP0302525A3 (en) Quinolones as antibacterial agents
NO173445C (en) Analogous methods for the preparation of therapeutically active quinoline carboxylic derivatives
DK0612731T3 (en) New quinolone and naphthyridone carboxylic acid derivatives
ATE207479T1 (en) CRYSTALS OF DERIVATIVES OF CHINOZONE CARBOXYLIC ACID HYDRATES
SE7810295L (en) SUBSTITUTED KINOLIN CARBOXYLIC ACID
FR2355822A1 (en) INDOLACETIC ACID ESTERS DERIVATIVES. USEFUL AS ANTI-INFLAMMATORY AND ANALGESICS
GB1515060A (en) 3-hydroxymethylene-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoline carboxylic acid esters
ES2054007T3 (en) QUINOLINE COMPOUND.
FI934303A0 (en) ACYLSULFONAMIDO-OCH SULPHONAMIDOPYRIDIN-2-CARBOXYLSYRAESTRAR OCH DERASPYRIDINE-N-OXIDER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDELEL
SE7713710L (en) PREPARATION OF NEW ETRs
FI922482A (en) FOERFARANDE FOER FRAMSTAELLNING AV KINOLINFOERENING.
ES481296A1 (en) Ester derivatives of quinolopyran-4-one-2-carboxylic acids and antiallergic antasthmatics
YU76593A (en) 1-SUPST.-6-FLUORO-4-OXO-7- (1-PIPERAZINYL) -1,4-DIHYDROHINOLINES-3-CARBOXYLIC ACIDS, A NEW INTERMEDIATE USED IN THIS PROCEDURE AND A PROCEDURE FOR OBTAINING INTERMEDIATE
ES2051225A1 (en) Procedure for preparation of 1-ethyl-6-fluoro-7-(pyrrol-1- yl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
ES2010462A6 (en) Ciprofloxacin bactericide prepn.
JPS54119428A (en) Novel benzoic acid derivative

Legal Events

Date Code Title Description
FD Application lapsed